A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin-Reference-Cited by-同舟云学术

A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin

Published:2011-10 Issue:4 Volume:128 Page:361-367
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Jeske Walter P.,Hoppensteadt Debra,Gray Angel,Walenga Jeanine M.,Cunanan Josephine,Myers Lauren,Fareed Jawed,Bayol Alain,Rigal Hélène,Viskov Christian

Publisher

Elsevier BV

Subject

Hematology

Reference23 articles.

1. Structural characterization of low molecular weight heparins;Casu;Semin Thromb Hemost,1999

2. Importance of a 3-O-sulfate in a heparin pentasaccharide for antithrombotic activity;Walenga;Thromb Res,1988

3. Heparin and low-molecular-weight heparin;Hirsh;Chest,2004

4. Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma;Alban;Semin Thromb Hemost,2001

5. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin;Holmer;Biochem J,1981

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoenzymatic synthesis of ultralow and low-molecular weight heparins;Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics;2020-02

2. The effect of bemiparin on neointimal hyperplasia and endothelial cell proliferation in a rabbit carotid artery model;The Turkish Journal of Thoracic and Cardiovascular Surgery;2017-04-18

3. Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis;Mini-Reviews in Medicinal Chemistry;2017-01-17

4. Recent advances in anticoagulant drug delivery;Expert Opinion on Drug Delivery;2015-12-23

5. Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial;Journal of Thrombosis and Haemostasis;2015-10-31